CorePharma®

CorePharma® stands as a leading US-based contract development and manufacturing organization (CDMO), dedicated to producing high-quality pharmaceuticals across a spectrum of therapeutic categories. CorePharma's commitment extends to providing comprehensive, end-to-end solutions, from the initial stages of drug development through to commercial launch and beyond, ensuring a seamless journey for their partners. The company's focus is on delivering excellence at every stage.

Operating with an outstanding regulatory inspection track record, CorePharma boasts three state-of-the-art facilities. These US FDA and DEA-registered sites are designed for development, analytical work, clinical trials, and commercial manufacturing and packaging. Together, they encompass 100,000 square feet and have an annual capacity to produce 4 billion dosage units. Located primarily at 215 Wood Avenue, Middlesex, NJ 08846, US, CorePharma ensures quality and efficiency throughout its operations.

CorePharma is committed to being the concept-to-commercial CDMO platform for success. With industry-leading lead times, CorePharma accelerates project timelines, enabling partners to move swiftly from the lab to the clinic and, ultimately, to the patient. CorePharma is here to help. Manager, we invite you to create a customized and exclusive company showcase and product listing on our platform to further highlight CorePharma’s capabilities.